Cynata Receives Ethics Approval to Commence Clinical Trial in COVID-19 and Clinical Development Update
8 May 2020 Cynata Therapeutics Limited, a clinical-stage biotechnology company specialising in cell therapeutics, is pleased to announce that it has received ethics committee approval to commence a clinical trial to investigate early efficacy of Cynata’s proprietary CymerusTM…
Florey researchers to pursue first-in-clinic treatment for severe infant epilepsy
8 May 2020 Researchers at the Florey, in collaboration with the University of Melbourne, will pursue a potentially life-changing precision medicine treatment for children with severe forms of epilepsy, thanks to a new multi-year grant awarded from the…
AdAlta update: Dr Tim Oldham interviewed by Pitt Street Research
8 May, 2020 Our CEO, Dr Tim Oldham recently sat down with Stuart Roberts of Pitt Street research to talk about AdAlta’s growth strategy and upcoming Phase 1 clinical trials of lead candidate, AD-214. In the interview, Dr…
Killing ‘sleeper cells’ may enhance breast cancer therapy
7 May 2020 The anti-cancer medicine venetoclax could improve the current therapy for estrogen receptor-positive (ER+) breast cancer – the most common form of breast cancer in Australia – according to preclinical studies led by Walter and Eliza…
Sienna enters New Zealand market with its hTERT IVD
6 May 2020 Sienna Cancer Diagnostics Ltd (ASX:SDX) (“Sienna” or “the Company”) is pleased to announce the appointment of Scientle Innovations (“Scientle”) as its exclusive distributor in New Zealand. The distribution agreement provides Scientle with the right to…
CSL Behring Australia Commences Development of Treatment for Serious Cases of COVID-19
6 May 2020 CSL Behring Australia, a subsidiary of CSL Limited, today announced that it will begin immediate onshore development of an anti-SARS-CoV-2 plasma product with the potential to treat people with serious complications of COVID-19, particularly those…
Over $33 million to boost genomics research into cancers and to combat children’s diseases
6 May 2020 Via the Hon Greg Hunt MP The Morrison Government has awarded over $33 million to Australia’s best and brightest researchers to combat high mortality and low survivability cancers and diseases, improve paediatric acute care using…
10M grant enables MCRI’s BCG vaccine trial to expand internationally, enrol 10,000 healthcare workers
5 May 2020 An A$10 million grant from the Bill & Melinda Gates Foundation will allow the Murdoch Children’s Research Institute’s (MCRI) clinical trial of the BCG vaccine against COVID-19 to extend to 10,000 healthcare workers across Australia, Spain and The Netherlands.…
VivaZome licenses University of Adelaide stem cell technology
5 May 2020 Melbourne and Adelaide, Australia: VivaZome Therapeutics Pty Ltd (“VivaZome”) and the University of Adelaide today announced that they have entered into a series of agreements encompassing licensing of technology, access to stem cells and conduct…
New Research Unveils the Secret Life of White Blood Cells
4 May 2020 New research led by scientists at the Australian Regenerative Medicine Institute (ARMI) has unveiled how white blood cells move and carry out their functions at the cellular and subcellular level – at a resolution at…
Noxopharm reports abscopal responses in prostate cancer trial
30 April 2020 Noxopharm (ASX:NOX) today releases details of the radiographic review of its DARRT-1 clinical study and is pleased to report that it shows a major benefit from a combination of Veyonda® and low-dose radiotherapy. The…
Stuart Elliott speaks on ABC Radio about manufacturing supply chain resilience
4 May 2020 Planet Innovation co-CEO and co-founder Stuart Elliott described the COVID-19 pandemic as a “wake-up call” for how medical products are sourced, in an interview with ABC Radio. Speaking with host Virginia Trioli on Wednesday morning,…
